No photo available
Sep 5, 2018 — Patented Universal Tumor-Targeting Drug Delivery Platform Co.
This pharmaceutical company has developed and patented a universal tumor-targeting drug-delivery platform that can improve the safety and efficacy of many existing chemo treatments, with the ability to target numerous different types of cancer. The technology encapsulates existing FDA-approved drugs inside lipid nanoparticles (liposomes or emulsions) coated with patented human-sourced antinuclear antibodies (ANA). The lipid nanoparticle provides long-term storage stability of the drug and controlled release of the drug over time at body-temperature, and is expected to improve the safety and efficacy profile of the drug, including passive accumulation at the tumor while not harming normal tissues. The Company’s ANA, sourced from lupus patients, binds to nuclear material present in abundance in areas of necrosis (dead / ruptured cells) present in and around all solid tumors, thus anchoring the drug-filled nanoparticles at the tumor where the nanoparticle is designed to slowly release the drug directly on the tumor for more effect. As the Company’s ANA is not tumor-marker specific, but rather targets necrosis present in solid tumors, the technology is designed to "universally" target many different types of cancer including breast cancer, lung, ovarian, colon, prostate, etc., as well as rare childhood cancers.
More Deals Like This One
Apr 5, 2018 — Urinary incontinence (UI) is a common and general term used for a roughly $3.4B urinary catheter marketplace worldwide. There are numerous causes for UI or instances where a catheter is needed, including but not limited to overactive bladder, prostate enlargement (aka Benign Prostate Hyperplasia or...
May 24, 2018 — Unique laboratory distribution company selling a wide range of products to the veterinarian laboratory market. 23 years old. Sells products in the US and International markets. Some products are proprietary to the company.
Sep 6, 2018 — The company is a developer, designer and manufacturer of bespoke, flexible polymer-based materials that are used by converters and manufacturers for specialist industry applications. They are the largest manufacturer of radiation protection material globally (using 600 tonnes of lead per annum). Radiation...
Oct 16, 2018 — $1.9M EBITDA Medical Equipment Company that serves the top hospitals in the nation with proprietary medical equipment to help serve patients and practitioners.
Nov 19, 2018 — This U.S. Company has been manufacturing Aspheric Optics using proprietary and innovative Computer-controlled Asphere Polishing processes for research, military, and commercial applications since 2002. Aspheric optics are used throughout sophisticated optical systems today. Uses include aspheres...